(BPT) - Exciting new research models and at-home clinical trials are shortening the distance between breakthrough science and the families who need it most.
For families facing a rare epilepsy diagnosis, the search for answers can feel long, uncertain and isolating. But as November marks National Epilepsy Awareness Month, emerging science is offering new reasons for hope — and bringing research closer to home than ever before.
A small, striped fish is helping epilepsy researchers move faster than ever, while new at-home trial options are bringing clinical research directly to families' doorsteps.
Zebrafish may be small, but they are a big help to scientists learning more about rare epilepsies. Seizures can be observed in genetically engineered zebrafish and monitored across hundreds of zebrafish larvae in real time. This allows scientists to quickly test and identify potential new treatments for these difficult-to-treat epilepsies.
"Zebrafish let us faithfully model human epilepsy conditions and screen thousands of drugs at a speed not possible in any other laboratory model," said Scott C. Baraban, Ph.D., University of California, San Francisco (UCSF) professor and a pioneer in zebrafish epilepsy research. Work in his laboratory using zebrafish led to the discovery of investigational study drugs now being evaluated in clinical trials for Dravet syndrome and Lennox-Gastaut syndrome. "For families who too often hear there are no treatment options, this approach gives them hope."
Breakthroughs like these are now reaching families more directly than ever. At-home clinical trials are opening the door for more people to participate in research without the burden of traveling long distances to specialized centers.
Tracy Dixon-Salazar, Ph.D., President and CEO of the LGS Foundation, and a mother who became a neuroscientist after her daughter was diagnosed with Lennox-Gastaut syndrome, added, "When a trial requires a family to fly across the country, the science exists, but it is still out of reach for most families living with LGS. Bringing trials into the home changes who can participate, and that changes who may benefit. No family should have to depend on geography or luck to get access to research."
Hope, though, still needs a map. For families anywhere along this journey, unsure of where to turn, here are five things to know.
5 things families should know about managing a rare epilepsy diagnosis
Rare epilepsies are more common — and more researched — than many families realize: While each individual condition is rare, collectively, rare epilepsies affect thousands of individuals. Active research communities, advocacy groups, and clinical programs are working to better understand them and develop new approaches.
Clinical trials aren't only a last resort option: Many families assume trials are reserved for when all else fails. But participating in research can be an informed choice at any stage of the patient's journey. Talking with your loved one's care team early and often can help you understand what may be appropriate.
At-home trial options may remove a major barrier: Clinical trials often require frequent, distant visits to specialized centers. Today, newer at-home study models can bring these trials directly to families — reducing travel burden and making research more accessible for those who need it most.
You don't have to navigate a rare epilepsy diagnosis alone: Patient advocacy organizations, rare disease foundations and epilepsy support networks can help families better understand their options, connect with specialists and find communities walking a similar path.
Curiosity is a strength — ask questions and keep learning: From the zebrafish in the laboratory to the families participating in at-home trials, progress in research depends on families who keep asking, "What's possible?" Speak with your health providers, continue learning and ask about at-home trial options that may be available to your loved ones.
The road through rare epilepsy has never been easy. But today, families aren't walking it alone — and the path forward is thankfully becoming shorter, more navigable and, increasingly, leads straight home.
